Irreversible Electroporation of Unresectable Liver Tumors

STATUS

Recruiting
End date

Mar 30, 2025
participants needed

15
sponsor

Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery

Send

Updated on 19 February 2024

See if I qualify

cancer

metastasis

liver tumor

hepatoma

biliary tract cancer

irreversible electroporation

Summary

The aim of this study is to evaluate the safety and feasibility of curative intended irreversible electroporation (IRE) in the treatment of liver tumors neighboring major vessels or bile ducts.

Description

Patients can be included in the study if they have one or more malignant liver tumors unsuitable for resection and thermal ablation (due to proximity of major vessels or bile duct) or other established liver directed therapies.

Prior to inclusion all potential participant will be evaluated by the local multidisciplinary team, to insure fulfillment of the above-mentioned criteria. In general, the included patient will have tumors with <1 cm of margin to major hepatic vessels or bile ducts, thereby not allowing for conventional treatments because of risk of i.e. hemorrhage, biliary tract damage, liver failure or ineffective ablation due to heat sink.

IRE will be done under general anesthesia as an in-patient procedure. Patients will be observed for at least 24 hours after IRE.

Patients will attend CT scans 1, 3, 6, 9, 12, 18, 24, 36, 48 and 60 months post-IRE according to national guidelines (for follow-up after radiofrequency ablation (RFA)). Patients will attend the out-patient clinic after 1, 3, 6, 9, 12, 18 and 24 months. During the follow-up period, patients will be asked to fill out electronic forms monitoring pain, quality of life and nutritional status. After 24 months the patients will only be followed with CT scans in accordance with the mentioned schedule. Data collection for scientific purposes will stop when the last included patient has been followed for at least 24 months or when the study period concludes.

In case of multiple liver tumors, where a conventional treatment approach is not possible due to a single lesion being too close to major vessels or bile ducts, IRE may be used in conjunction to conventional therapy.

Details

Condition	Bile duct carcinoma, Adenocarcinoma, Adenocarcinoma, Biliary neoplasm, HEPATIC NEOPLASM, liver cancer, HEPATOCELLULAR CARCINOMA, Liver Metastases, liver cancer
Age	18years - 100years
Treatment	Irreversible electroporation
Clinical Study Identifier	NCT04404647
Sponsor	Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Primary or secondary cancer of the liver
	Largest tumor diameter 5 cm in any plane
	Tumor must be deemed as unresectable and unsuitable for other established curative liver directed therapies
	Treatment must be given with curative intent
	Patients must be able to give informed consent
Exclusion Criteria
	Radiological signs of synchronous intra- or extrahepatic disease, unless curative intended therapy is planned
	Tumor is inaccessible e.g. due to venous dilation etc. (assessed with preoperative ultrasound)
	American Society of Anesthesiologists (ASA) score >3
	Eastern Cooperative Oncology Group (ECOG) performance status >2
	Child-Pugh class C
	International Normalized Ratio (INR)>1.5
	Pregnancy
	Persistent atrial fibrillation
	Implanted electronic devices e.g. cardiac pacemakers or other electrostimulators
	Metal stents or other metallic objects near the ablation zone (unless the stent can be replaced with a plastic stent prior to IRE)
	Severe allergies to anesthetic agent, paralytic agent or any of the equipment used during treatment
	Patient is referred from a hospital outside of Denmark

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

irreversible electroporation

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Irreversible Electroporation of Unresectable Liver Tumors